Provided by Tiger Fintech (Singapore) Pte. Ltd.

Certara, Inc.

14.15
+0.62004.58%
Post-market: 14.00-0.1500-1.06%19:59 EDT
Volume:2.11M
Turnover:29.48M
Market Cap:2.28B
PE:-176.88
High:14.17
Open:13.56
Low:13.43
Close:13.53
Loading ...

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

GlobeNewswire
·
14 Apr

Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization

THOMSON REUTERS
·
14 Apr

Certara Inc - Reiterates Full Year 2025 Revenue Guidance of $415-$425 Million

THOMSON REUTERS
·
14 Apr

Certara Inc - Authorizes $100 Million Stock Repurchase Program

THOMSON REUTERS
·
14 Apr

Certara Inc - Reiterates Full Year 2025 Adjusted EPS of $0.42-$0.46

THOMSON REUTERS
·
14 Apr

Press Release: Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization

Dow Jones
·
14 Apr

Why Certara Inc. (CERT) Surged On Friday?

Insider Monkey
·
12 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Wells Fargo, American Express, Mondelez

Reuters
·
12 Apr

Certara Up Over 15%, on Pace for Largest Percent Increase Since March 2023 -- Data Talk

Dow Jones
·
11 Apr

Certara trading resumes

TIPRANKS
·
11 Apr

Shares of AI-Based Drug Developers up on US FDA's Plans to Replace Animal Testing

THOMSON REUTERS
·
11 Apr

Recursion Pharmaceuticals up 9.3%, Absci up 10.9%, Schrodinger up 4.5% and Certara up 10.9%

THOMSON REUTERS
·
11 Apr

US FDA to Phase Out Animal Testing in Drug Development, Adopt AI Methods

Reuters
·
11 Apr

BUZZ-Certara jumps as FDA moves to replace animal testing

Reuters
·
11 Apr

Certara Is Maintained at Equal-Weight by Barclays

Dow Jones
·
10 Apr

Certara price target lowered to $11 from $13 at Barclays

TIPRANKS
·
10 Apr

Leerink Partners Sticks to Their Hold Rating for Certara (CERT)

TIPRANKS
·
08 Apr

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

GlobeNewswire
·
01 Apr

At US$9.91, Is Certara, Inc. (NASDAQ:CERT) Worth Looking At Closely?

Simply Wall St.
·
29 Mar

Arvinas (ARVN) Moves 8.8% Higher: Will This Strength Last?

Zacks
·
13 Mar